Mylan Laboratories to acquire unit VI manufacturing plant from SMS Pharmaceuticals - MarketLine Financial Deals

Mylan Laboratories to acquire unit VI manufacturing plant from SMS Pharmaceuticals

Mylan Laboratories to acquire unit VI manufacturing plant from SMS Pharmaceuticals - MarketLine Financial Deals
Mylan Laboratories to acquire unit VI manufacturing plant from SMS Pharmaceuticals
Published Oct 17, 2012
2 pages — Published Oct 17, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Mylan Laboratories Limited, a subsidiary of Mylan, Inc., has agreed to acquire the unit VI manufacturing plant at Visakhapatnam, Andhra Pradesh from SMS Pharmaceuticals, Ltd.

  
Source:
Document ID
MA126322_121022
Country
Country
Ticker
524794=IN
Ticker
532815=IN
Ticker
MYL=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Mylan Laboratories to acquire unit VI manufacturing plant from SMS Pharmaceuticals" Oct 17, 2012. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Mylan-Laboratories-to-acquire-unit-VI-manufacturing-plant-from-SMS-Pharmaceuticals-2052-88259>
  
APA:
MarketLine Financial Deals. (2012). Mylan Laboratories to acquire unit VI manufacturing plant from SMS Pharmaceuticals Oct 17, 2012. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Mylan-Laboratories-to-acquire-unit-VI-manufacturing-plant-from-SMS-Pharmaceuticals-2052-88259>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.